Product logins

Find logins to all Clarivate products below.


Joel Haspel

SVP Corporate Strategy, Science Group​

Joel’s current responsibilities include enterprise and business strategy across the One Clarivate four industry segments, competitive intelligence and M&A. He brings extensive experience built over 32 years working with customers globally across industries, with 13 of those years focused on life sciences and healthcare. Joel has a passion for the use of digital technologies by medical professionals and patients and serves on the board of two innovative digital health companies, FollowApp Care and Lifelight.

arrow_forwardDownload bio

Latest news

News September 17, 2026
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate”), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has commenced a…

News September 17, 2026
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

22 researchers honored for Nobel-class discoveries, including pioneers of GLP-1 medicines and other world-changing advances London, U.K. September 17, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence,…

News September 14, 2026
Clarivate and ODIN to Launch First Multi-State Resource Sharing Network Across the Dakotas

Rapido, Clarivate’s library resource sharing platform, to connect libraries across North and South Dakota, expanding access to collections London, U.K. September 14, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.